Alkermes plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALKS Nasdaq 2836 www.alkermes.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alkermes plc

Is Alkermes (ALKS) Priced For Orexin Success Or Too Rich? - Aug 1st, 2026 2:12 am
Alkermes (ALKS) Reported Mixed Q2 Results, Does It Look Fairly Valued? - Jul 31st, 2026 6:15 pm
Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says - Jul 29th, 2026 9:54 am
Alkermes plc Q2 2026 Earnings Call Summary - Jul 29th, 2026 6:30 am
Alkermes PLC (ALKS) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amidst Competitive ... - Jul 28th, 2026 1:01 pm
Alkermes Q2 Earnings Break Even, Revenues Beat Estimates, Stock Down - Jul 28th, 2026 9:21 am
Alkermes Q2 Earnings Call Highlights - Jul 28th, 2026 8:04 am
Compared to Estimates, Alkermes (ALKS) Q2 Earnings: A Look at Key Metrics - Jul 28th, 2026 7:30 am
Alkermes (ALKS) Reports Break-Even Earnings for Q2 - Jul 28th, 2026 6:15 am
Alkermes plc Reports Second Quarter 2026 Financial Results - Jul 28th, 2026 5:00 am
Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Jul 22nd, 2026 8:00 am
Alkermes (ALKS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Jul 21st, 2026 8:00 am
Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance - Jul 16th, 2026 9:58 am
Alkermes to Report Second Quarter Financial Results on July 28, 2026 - Jul 14th, 2026 2:00 pm
American Express, Biogen upgraded: Wall Street's top analyst calls - Jul 13th, 2026 7:41 am
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis - Jul 13th, 2026 5:00 am
Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar? - Jul 3rd, 2026 5:06 am
Alkermes (ALKS) Is Up 9.3% After Strong Alixorexton Phase 2 Data And Russell 2000 Addition - What's Changed - Jun 30th, 2026 8:07 am
Sector Update: Healthcare Stocks Higher Late Afternoon - Jun 29th, 2026 1:59 pm
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation? - Jun 29th, 2026 11:41 am